| Future Health Pharma GmbH - Rasilez HCT 300mg/12.5mg, Filmtabletten |
| 58935 | | 03 | | Rasilez HCT 300mg/12.5mg | | Filmtabletten | | C09XA52 | | Aliskiren and Hydrochlorothiazide | | 28.10.2008 | | |
|
| Composition |
| aliskirenum 300 mg ut aliskireni hemifumaras, hydrochlorothiazidum 12.5 mg, excipiens pro compresso obducto. |
| Packungsbestandteile |
| Coated tablets | | | | | | | | Active Agent | Dose |
|---|
| Aliskirenum | 300 mg correspond Aliskireni Hemifumaras | | Hydrochlorothiazide | 12.5 mg |
| | BAG: Active Agent | Dose |
|---|
| Aliskirenum | 300 mg | | Hydrochlorothiazide | 12.5 mg |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
